• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

Treatment discontinuation in MS: the DOT-MS trial

May 5, 2025  

CLINICAL CASES IN MS: A 24 Y.O. WOMAN WITH PARESTHESIAE AND NON-ENHANCING LESIONS

April 25, 2025  

AAN 2025 – report on fluid biomarkers in MS

April 22, 2025  

Ofatumumab – new data on efficacy and safety

April 14, 2025  

AAN DAILY HIGHLIGHTS – WEDNESDAY, APRIL 9, 2025

April 9, 2025  

AAN DAILY HIGHLIGHTS – TUESDAY, APRIL 8, 2025

April 8, 2025  

AAN DAILY HIGHLIGHTS – MONDAY, APRIL 7, 2025

April 7, 2025  

ACTRIMS Forum 2025 highlights – Update on ocrelizumab

March 24, 2025  

ACTRIMS Forum 2025: Update on biomarkers

March 17, 2025  

CLINICAL CASES IN MS: A PATIENT WITH WORSENING FATIGUE AND NEW MOBILITY PROBLEMS

March 13, 2025  
1
2
3
Next

Browse by Topic

  • EPILEPSY (36)
  • MS (412)
  • CLINICAL CASES IN MS (15)
  • BIOMARKERS IN MS (54)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • CLINICAL CASES IN MS: A 24 Y.O. WOMAN WITH PARESTHESIAE AND NON-ENHANCING LESIONS posted on April 25, 2025
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Ofatumumab – new data on efficacy and safety posted on April 14, 2025
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions